Article
Humanigen Inks First Asia Licensing Deal For Its Covid-19 Treatment | Sports Grind Entertainment
Rating:
0.0
Views:
99
Likes:
1
Library:
1
Humanigen (HGEN) has announced the execution of its first licensing transaction in the Asia-Pacific Region with Telcon RF Pharmaceutical, Inc. and KPM Tech Co., Ltd for development and commercialization rights to lenzilumab for COVID-19 for South Korea and the Philippines.Shares in HGEN are rising 4.2% in Tuesday's pre-market trading.Telcon is an affiliate of KPM Tech and both companies recently invested […]
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value